Durham Biomedical Consortium Awarded $45M Federal ARPA-H Grant for Gene Therapy
Duke University, NC Central University, and UNC Chapel Hill medical researchers unite to build rapid-deployment vaccine manufacturing hub in Downtown Durham.
The federal Advanced Research Projects Agency for Health (ARPA-H) selected the Research Triangle Biomedical Consortium for a multi-year $45 million research award to streamline cell and gene therapy production.
Based in downtown Durham’s Innovation District, the consortium combines bioprocessing laboratories at Duke Health and UNC Lineberger Comprehensive Cancer Center with specialized workforce apprenticeships at North Carolina Central University.
The North Carolina day, before it begins. In one email.
Every weekday at 6:30 a.m. we deliver the stories shaping the Old North State: General Assembly action, Research Triangle and Charlotte business, ACC scores, and deep investigative accountability. Written by reporters, edited by humans.
Search NewsToToday
Type at least two characters to search the archive…
